AMSTERDAM, April 23, 2015 /PRNewswire/ --
Event is integral to regional growth as Government seeks to boost domestic manufacturing production
CPhI Russia @ IPhEB, organised by UBM EMEA, returns for the third consecutive year, taking place at JSC VDNH (VVC), Moscow, 27th-29th April 2015. This year, CPhI Russia @ IPhEB co-locates with P-MEC and InnoPack, as well as new additions Food ingredients (Fi) and Health ingredients Russia (Hi).
(Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )
CPhI Russia @ IPhEB continues to expand year-on-year, keeping pace with the industry's growth and providing a large, varied portfolio for attendees. In 2015, the six-in-one event moves to the nation's capital and expands to a full three-day event. It is now the central hub for exhibitors and attendees within the region, providing a vital platform where pharma executives can connect, build relationships and enhance their business opportunities.
Russia's pharmaceutical market has been forecast to reach $25 billion by 2018 - it is currently growing at an annual growth rate of 10%, making it one of the fastest growing markets in the world. The pharma market, in particular, has seen the benefits of Russia's expanding economy and with increased Government investment in healthcare, it is expected that the Russia pharmaceutical industry will see a sustained period of expansion over the next few years.
The country has attracted a strong base of international pharma companies - an overwhelming 76% of total pharmaceutical sales are attributed to imported drugs - with many more foreign manufacturers now looking to capitalise on this attractive market.
Russia's Government, which implemented a Pharma 2020 plan, is actively looking to boost the domestic pharma manufacturing base and meet the rising drug demand resulting from greater disposable incomes and an increasingly health conscious population. Government support has been a key driver of this thriving market. The Ministry of Industry and Trade of the Russian Federation are exhibiting at CPhI Russia @ IPhEB - stand 423 - and are also providing their vital perspectives directly into the Conference programme.
Highlights of CPhI Russia 2015
" IPhEB & CPhI Russia has become an iconic place of meeting for the partners from around the world. Here we can see the latest trends, new products, discuss the latest developments. In brief, you can feel the spirit of the international pharmaceutical market," said Vikram Singh Punia, President at Pharmasyntez, a Russian company that designs and manufactures high quality, innovative medicines.
Pharmasyntez is a platinum sponsor and will be exhibiting at stand 202 throughout the event. Another platinum sponsor for CPhI @ IPhEB, Pharmcontract - the Russian multi chemical and pharmaceutical holding, specialising in the development of innovative production technologies - will be exhibiting at stand 423.
Erick Heemsterk, Brand Director Pharma at UBM EMEA, commenting on the impact CPhI Russia @ IPhEB is having on the region:
"Pharma in Russia is a bold new industry that is still being shaped by a thriving economic landscape and a dominant international presence. The continual evolution of the region makes for an extremely appealing market for foreign investment and CPhI @ IPhEB provides the ideal platform for domestic and international buyers and supplies to ignite business opportunities together.
"We are delighted to bring our evolving event portfolio to the Nation's Capital this year and believe it is a great opportunity to cement CPhI @ IPhEB as the must-attend event for pharma executives."
To register online and learn more about CPhI Russia @ IPhEB visit: http://www.cphi.com/russia/home
Notes to editors
About CPhI
CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, Southeast Asia, Istanbul and Russia, and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.
For more information visit: http://www.cphi.com
The UBM EMEA annual schedule of Pharmaceutical events includes; CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (22-24 April, 2015 at the Big Sight Exhibition Centre- Tokyo). CPhI Russia and IPhEB (27-29 April, 2015 at the VVC, Pavilion Nr 75, Moscow Russia); CPhI Istanbul (3-5 June, 2015, at the Lutfi Kirdar Convention and Exhibition Centre- Turkey); CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (24-26 June, 2015 at SNIEC- Shanghai, China); CPhI, ICSE Korea (7-9 September, 2015 at the COEX- Seoul, South Korea); CPhI, ICSE, P-MEC and InnoPack Worldwide (13-15 October 2015, IFEMA- Feria de Madrid, Spain) CPhI, P-MEC, ICSE and BioPh India (1-3 December, 2015 at the Bombay Convention and Exhibition Centre, Mumbai, India).
About UBM EMEA
UBM EMEA connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.
For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44-207-203-6745 / 6740
E: a.heeley@defacto.com / t.jervis@defacto.com
Share this article